Restoring Radioiodine Uptake in BRAF V600E–Mutated Papillary Thyroid Cancer

This image illustrates a multimodal therapeutic strategy for an iodine-refractory BRAF-mutated metastatic papillary thyroid carcinoma with reversed radioiodine resistance using BRAF inhibitors.

Detalles Bibliográficos
Autores principales: Huillard, Olivier, Tenenbaum, Florence, Clerc, Jerome, Goldwasser, Francois, Groussin, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2017
Materias:
Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686703/
https://www.ncbi.nlm.nih.gov/pubmed/29264486
http://dx.doi.org/10.1210/js.2016-1114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686703/
https://www.ncbi.nlm.nih.gov/pubmed/29264486
http://dx.doi.org/10.1210/js.2016-1114

Ejemplares similares